Rapport Therapeutics, Inc. ($RAPP)
Bredt David โ Chief Scientific Officer
Shares
6,000
Price
$1.80
Total Value
$10,800.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Bredt David |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Feb 19, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 20, 2026 |
| Document Date | Feb 17, 2026 |
| Shares Purchased | 6,000 |
| Price per Share | $1.80 |
| Total Value | $10,800.00 |
| Shares Owned After | 393,075 |
| Derivative | No |
| Accession Number | 0001193125-26-059883 |
| Document | View SEC Filing |